Kidney Failure, Chronic
11 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.
Broader: Kidney Diseases, Renal Insufficiency, Renal Insufficiency, Chronic
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| 10 GE Xenokidney for kidney failure, chronic | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Arm 2A: TRACT/MONO mTOR for kidney failure, chronic | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Arm 2B: TRACT/MONO CNI for kidney failure, chronic | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| AZD7760 for kidney failure, chronic | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Belantamab mafodotin for kidney failure, chronic | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| ChoironeX GalKO Porcine Thymokidney for kidney failure, chronic | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Empagliflozin for kidney failure, chronic | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Ex Vivo CRISPR-Cas9 Gene Editing of Donor Kidney + Kidney Transplantation with Standard Care for kidney failure, chronic | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| GGTA1 KO Thymokidney for kidney failure, chronic | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Retatrutide for kidney failure, chronic | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| UKidney for kidney failure, chronic | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.